Details
- Manufacturer
- Baxter AG
- ATC code
- L01DB01
- Status
- 9 abgeschlossen
- Reported since
- 328 days
- First report
- 01.07.2022
- Active substance
- doxorubicini hydrochloridum
- Swissmedic no.
- 5427301
- Public price (PPUB)
- CHF 180.45
- Ex-factory price (PEXF)
- CHF 148.72
- Product information (AIPS)
- swissmedicinfo.ch →
Composition
doxorubicini hydrochloridum 2 mg, N-(carbonyl-methoxypolyethylenglycoli 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolaminum natricum, phosphatidylcholinum ex soja hydrogenatum, cholesterolum, ammonii sulfas, saccharum, histidinum, acidum hydrochloridum aut natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1 ml corresp. natrium 0.054 mg.
Historical history
This product (or one with the same active substance) has already been 7× in shortage.
DOXORUBICIN Teva 10 mg/5ml Durchstf 5 ml189 days
ADRIBLASTIN RD Trockensub 10 mg c Solv Durchstf55 days
DOXORUBICIN Sandoz eco 100 mg/50ml 50 ml51 days
ADRIBLASTIN Solution 10 mg/5ml Cytosafe 5 ml36 days
ADRIBLASTIN Solution 50 mg/25ml 2 Cytosafe 25 ml30 days
DOXORUBICIN Sandoz eco 10 mg/5ml 5 ml30 days
DOXORUBICIN Teva 50 mg/25ml Durchstf 25 ml30 days
Source: drugshortage.ch · no warranty of completeness